Search results
I'm 49 and Just Had My First Facial. Here's What Happened - E! Online
E! Online· 56 minutes agoJoanna says the Triple Crown facial is "by far our most popular facial." 1. Microdermabrasion: The...
Topical Treatment Effective for Young Kids Up to 52 Weeks
Medscape· 2 days agoNo treatment-related interruptions, discontinuations, or serious adverse events were observed with...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 6 days agoIt will be important to watch how Pfizer stock performs as the company shores up its pipeline and...
My sudden symptoms left doctors stumped—until a rare diagnosis
Newsweek· 5 days agoAlthough I didn't know it then, I'd developed Postural Orthostatic Tachycardia Syndrome, or POTS, a...
Upadacitinib Improves Giant Cell Arteritis in Phase 3 Trial
Medscape· 5 days agoThe primary endpoint of sustained remission — the absence of GCA signs or symptoms from weeks 12 to...
ESOPEC: FLOT Bests CROSS in Resectable Esophageal Cancer
Medscape· 7 days agoThe new findings help settle a long-standing debate and will impact disease management, but local...
Why Regeneron Stock Finally Joined The 1,000-Club
Investor's Business Daily· 6 days agoEnthusiasm is growing for a looming approval in COPD treatment.
Gilligan: Another chapter opens among life's milestones
telegraphherald.com· 19 hours agoI started writing a weekly column in the Telegraph Herald 30 years ago. A year before that, I’d...
Newer Therapies Target Different Melasma Components
Medscape· 7 days agoThe pathogenesis of melasma is complex, with genetic, hormonal, and other components that may play a role when choosing treatments, Nada Elbuluk, MD,...
Live from EHA 2024 | Posters Featuring Results from Three Studies of Olverembatinib, Including...
FOX 23 News Albany· 20 hours agoIn the results, olverembatinib showed excellent durable clinical benefits and favorable long-term tolerability in patients who had been treated with multiple TKIs (including ...